Global Pharmaceutical Testing Services

Pharmaceutical Testing Services Comprehensive Study by Testing Service (Bioanalytical Testing, Method Development & Validation, Raw Materials Testing, API Quality Control, In-Process and Product Release Testing, Finished Pharmaceutical Products Testing, Others), End-User (Pharmaceutical and Biopharmaceutical Companies, Biotechnology Industry) Players and Region - Global Market Outlook to 2030

Pharmaceutical Testing Services Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 10.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
The pharmaceutical analysis serves a diversity of purposes as it is frequently used to identify the chemical composition and molecular structure of each individual substance contained in a medication. Pharmaceutical testing can disclose a pharmaceutical's solubility and can forecast the medication's capability to reach a specific target within the body. Testing may even disclose contamination in the manufacturing production process or highlight other, earlier unknown risks with the formulation. Pharmaceutical testing services are services offered to numerous pharmaceutical manufacturers, product manufacturers, and raw material suppliers. The need for increased efficiency and cost reduction by pharmaceutical companies has led to the rising opportunity for outsourcing analytical testing services.

Highlights from Pharmaceutical Testing Services Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR10.5%


The key Players profiled in the report are Eurofins Scientific SE (Luxembourg), SGS (France), Envigo (United States), Exova Group PLC (United Kingdom), PPD Inc. (United States), Pace Analytical Services Inc. (United States), Intertek Group (United Kingdom), DYNALABS (United States), RD Laboratories (United States), ADPEN Laboratories (United States), West Pharmaceutical Services, Inc. (United States), Boston Analytical (United States), Accuratus Labs (United States), Microbac (United States), Charles River Laboratories International, Inc. (United States) and ARLBioPharma, Inc. (United States). Additionally, other players that are part of this comprehensive study are Lapuck Laboratories, Inc. (United States) and BioScreen Inc. (United States).

Geographic Breakdown and Segment Analysis
The Global Pharmaceutical Testing Services market presents a comprehensive analysis of the Pharmaceutical Testing Services market and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Pharmaceutical Testing Services industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Pharmaceutical Testing Services market

Analyst at AMA have segmented the market study of Global Pharmaceutical Testing Services market by Type, Application and Region.

Influencing Trend:
Growing Number of Clinical Trials and Increase in R&D Spending

Market Growth Drivers:
Companies are Gaining Efficacy in Specialized Testing for Product Verification Validation and Increasing Demand with Regard To Biological and Chemical Substances

Restraints:
Fluctuations in Regulatory Policies

Opportunities:
Companies Are Building a Solid Reputation with Pharmaceutical Companies to Conduct Analysis

Market Developments Activities:
On December 13, 2023 – Sterling Accuris Diagnostics, a leading chain of NABL-accredited pathology laboratories has announced the acquisition of Ahmedabad based Vaibhav Analytical Services, a leading provider of analytical testing services, including pharmaceutical/drug testing. With this acquisition, Sterling Accuris has successfully expanded its range of services offered to fields such as pharmaceutical analytical testing.
On March 2024, Element Materials Technology launched its Rapid Response Pharmaceutical Testing Service in its Manchester laboratory, providing expedited testing for customers around the world. The service will focus on various testing requirements, including active pharmaceutical ingredients (API) and final drug products, extractables and leachables, degradation production, and elemental impurities.

Regulatory Insights:
Before the medications are sold to consumers, they must be approved by the FDA’s Center for Drug Evaluation and Research. Any pharmaceutical product manufacturer requires quality control which is one of the Prerequisites to regulatory compliances. A significant portion of the cGMP regulations and all pharmacopeia methods such as USP, IP, EP, JP, BP, and In-house methods pertain to the quality control testing of products

The companies are involved in the testing and development of new bilirubin blood testing equipment and techniques. They form joint ventures, mergers, and acquisitions to launch new devices. Their primary goal is to provide devices that are cost-effective, easy to use, and produce tangible results.

Key Target Audience
Pharmaceutical Testing Service Providers, Pharmaceutical Companies, Regulatory Bodies, Governmental Bodies and Others

Report Objectives / Segmentation Covered

By Testing Service
  • Bioanalytical Testing
  • Method Development & Validation
  • Raw Materials Testing
  • API Quality Control
  • In-Process and Product Release Testing
  • Finished Pharmaceutical Products Testing
  • Others

By End-User
  • Pharmaceutical and Biopharmaceutical Companies
  • Biotechnology Industry

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Companies are Gaining Efficacy in Specialized Testing for Product Verification Validation
      • 3.2.2. Increasing Demand with Regard To Biological and Chemical Substances
    • 3.3. Market Trends
      • 3.3.1. Growing Number of Clinical Trials and Increase in R&D Spending
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical Testing Services, by Testing Service, End-User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical Testing Services (Value)
      • 5.2.1. Global Pharmaceutical Testing Services by: Testing Service (Value)
        • 5.2.1.1. Bioanalytical Testing
        • 5.2.1.2. Method Development & Validation
        • 5.2.1.3. Raw Materials Testing
        • 5.2.1.4. API Quality Control
        • 5.2.1.5. In-Process and Product Release Testing
        • 5.2.1.6. Finished Pharmaceutical Products Testing
        • 5.2.1.7. Others
      • 5.2.2. Global Pharmaceutical Testing Services by: End-User (Value)
        • 5.2.2.1. Pharmaceutical and Biopharmaceutical Companies
        • 5.2.2.2. Biotechnology Industry
      • 5.2.3. Global Pharmaceutical Testing Services Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global Pharmaceutical Testing Services (Price)
  • 6. Pharmaceutical Testing Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eurofins Scientific SE (Luxembourg)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. SGS (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Envigo (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Exova Group PLC (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. PPD Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pace Analytical Services Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Intertek Group (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. DYNALABS (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. RD Laboratories (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ADPEN Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. West Pharmaceutical Services, Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Boston Analytical (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Accuratus Labs (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Microbac (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Charles River Laboratories International, Inc. (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
      • 6.4.16. ARLBioPharma, Inc. (United States)
        • 6.4.16.1. Business Overview
        • 6.4.16.2. Products/Services Offerings
        • 6.4.16.3. Financial Analysis
        • 6.4.16.4. SWOT Analysis
  • 7. Global Pharmaceutical Testing Services Sale, by Testing Service, End-User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical Testing Services (Value)
      • 7.2.1. Global Pharmaceutical Testing Services by: Testing Service (Value)
        • 7.2.1.1. Bioanalytical Testing
        • 7.2.1.2. Method Development & Validation
        • 7.2.1.3. Raw Materials Testing
        • 7.2.1.4. API Quality Control
        • 7.2.1.5. In-Process and Product Release Testing
        • 7.2.1.6. Finished Pharmaceutical Products Testing
        • 7.2.1.7. Others
      • 7.2.2. Global Pharmaceutical Testing Services by: End-User (Value)
        • 7.2.2.1. Pharmaceutical and Biopharmaceutical Companies
        • 7.2.2.2. Biotechnology Industry
      • 7.2.3. Global Pharmaceutical Testing Services Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global Pharmaceutical Testing Services (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical Testing Services: by Testing Service(USD Million)
  • Table 2. Pharmaceutical Testing Services Bioanalytical Testing , by Region USD Million (2018-2023)
  • Table 3. Pharmaceutical Testing Services Method Development & Validation , by Region USD Million (2018-2023)
  • Table 4. Pharmaceutical Testing Services Raw Materials Testing , by Region USD Million (2018-2023)
  • Table 5. Pharmaceutical Testing Services API Quality Control , by Region USD Million (2018-2023)
  • Table 6. Pharmaceutical Testing Services In-Process and Product Release Testing , by Region USD Million (2018-2023)
  • Table 7. Pharmaceutical Testing Services Finished Pharmaceutical Products Testing , by Region USD Million (2018-2023)
  • Table 8. Pharmaceutical Testing Services Others , by Region USD Million (2018-2023)
  • Table 9. Pharmaceutical Testing Services: by End-User(USD Million)
  • Table 10. Pharmaceutical Testing Services Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2018-2023)
  • Table 11. Pharmaceutical Testing Services Biotechnology Industry , by Region USD Million (2018-2023)
  • Table 12. South America Pharmaceutical Testing Services, by Country USD Million (2018-2023)
  • Table 13. South America Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 14. South America Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 15. Brazil Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 16. Brazil Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 17. Argentina Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 18. Argentina Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 19. Rest of South America Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 20. Rest of South America Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 21. Asia Pacific Pharmaceutical Testing Services, by Country USD Million (2018-2023)
  • Table 22. Asia Pacific Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 23. Asia Pacific Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 24. China Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 25. China Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 26. Japan Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 27. Japan Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 28. India Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 29. India Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 30. South Korea Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 31. South Korea Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 32. Taiwan Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 33. Taiwan Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 34. Australia Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 35. Australia Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 37. Rest of Asia-Pacific Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 38. Europe Pharmaceutical Testing Services, by Country USD Million (2018-2023)
  • Table 39. Europe Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 40. Europe Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 41. Germany Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 42. Germany Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 43. France Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 44. France Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 45. Italy Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 46. Italy Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 47. United Kingdom Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 48. United Kingdom Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 49. Netherlands Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 50. Netherlands Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 51. Rest of Europe Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 52. Rest of Europe Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 53. MEA Pharmaceutical Testing Services, by Country USD Million (2018-2023)
  • Table 54. MEA Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 55. MEA Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 56. Middle East Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 57. Middle East Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 58. Africa Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 59. Africa Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 60. North America Pharmaceutical Testing Services, by Country USD Million (2018-2023)
  • Table 61. North America Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 62. North America Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 63. United States Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 64. United States Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 65. Canada Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 66. Canada Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 67. Mexico Pharmaceutical Testing Services, by Testing Service USD Million (2018-2023)
  • Table 68. Mexico Pharmaceutical Testing Services, by End-User USD Million (2018-2023)
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Pharmaceutical Testing Services: by Testing Service(USD Million)
  • Table 86. Pharmaceutical Testing Services Bioanalytical Testing , by Region USD Million (2025-2030)
  • Table 87. Pharmaceutical Testing Services Method Development & Validation , by Region USD Million (2025-2030)
  • Table 88. Pharmaceutical Testing Services Raw Materials Testing , by Region USD Million (2025-2030)
  • Table 89. Pharmaceutical Testing Services API Quality Control , by Region USD Million (2025-2030)
  • Table 90. Pharmaceutical Testing Services In-Process and Product Release Testing , by Region USD Million (2025-2030)
  • Table 91. Pharmaceutical Testing Services Finished Pharmaceutical Products Testing , by Region USD Million (2025-2030)
  • Table 92. Pharmaceutical Testing Services Others , by Region USD Million (2025-2030)
  • Table 93. Pharmaceutical Testing Services: by End-User(USD Million)
  • Table 94. Pharmaceutical Testing Services Pharmaceutical and Biopharmaceutical Companies , by Region USD Million (2025-2030)
  • Table 95. Pharmaceutical Testing Services Biotechnology Industry , by Region USD Million (2025-2030)
  • Table 96. South America Pharmaceutical Testing Services, by Country USD Million (2025-2030)
  • Table 97. South America Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 98. South America Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 99. Brazil Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 100. Brazil Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 101. Argentina Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 102. Argentina Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 103. Rest of South America Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 104. Rest of South America Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 105. Asia Pacific Pharmaceutical Testing Services, by Country USD Million (2025-2030)
  • Table 106. Asia Pacific Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 107. Asia Pacific Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 108. China Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 109. China Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 110. Japan Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 111. Japan Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 112. India Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 113. India Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 114. South Korea Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 115. South Korea Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 116. Taiwan Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 117. Taiwan Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 118. Australia Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 119. Australia Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 120. Rest of Asia-Pacific Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 121. Rest of Asia-Pacific Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 122. Europe Pharmaceutical Testing Services, by Country USD Million (2025-2030)
  • Table 123. Europe Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 124. Europe Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 125. Germany Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 126. Germany Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 127. France Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 128. France Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 129. Italy Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 130. Italy Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 131. United Kingdom Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 132. United Kingdom Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 133. Netherlands Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 134. Netherlands Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 135. Rest of Europe Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 136. Rest of Europe Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 137. MEA Pharmaceutical Testing Services, by Country USD Million (2025-2030)
  • Table 138. MEA Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 139. MEA Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 140. Middle East Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 141. Middle East Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 142. Africa Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 143. Africa Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 144. North America Pharmaceutical Testing Services, by Country USD Million (2025-2030)
  • Table 145. North America Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 146. North America Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 147. United States Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 148. United States Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 149. Canada Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 150. Canada Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 151. Mexico Pharmaceutical Testing Services, by Testing Service USD Million (2025-2030)
  • Table 152. Mexico Pharmaceutical Testing Services, by End-User USD Million (2025-2030)
  • Table 153. Research Programs/Design for This Report
  • Table 154. Key Data Information from Secondary Sources
  • Table 155. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical Testing Services: by Testing Service USD Million (2018-2023)
  • Figure 5. Global Pharmaceutical Testing Services: by End-User USD Million (2018-2023)
  • Figure 6. South America Pharmaceutical Testing Services Share (%), by Country
  • Figure 7. Asia Pacific Pharmaceutical Testing Services Share (%), by Country
  • Figure 8. Europe Pharmaceutical Testing Services Share (%), by Country
  • Figure 9. MEA Pharmaceutical Testing Services Share (%), by Country
  • Figure 10. North America Pharmaceutical Testing Services Share (%), by Country
  • Figure 11. Global Pharmaceutical Testing Services share by Players 2023 (%)
  • Figure 12. Global Pharmaceutical Testing Services share by Players (Top 3) 2023(%)
  • Figure 13. Global Pharmaceutical Testing Services share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Eurofins Scientific SE (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 16. Eurofins Scientific SE (Luxembourg) Revenue: by Geography 2023
  • Figure 17. SGS (France) Revenue, Net Income and Gross profit
  • Figure 18. SGS (France) Revenue: by Geography 2023
  • Figure 19. Envigo (United States) Revenue, Net Income and Gross profit
  • Figure 20. Envigo (United States) Revenue: by Geography 2023
  • Figure 21. Exova Group PLC (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Exova Group PLC (United Kingdom) Revenue: by Geography 2023
  • Figure 23. PPD Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. PPD Inc. (United States) Revenue: by Geography 2023
  • Figure 25. Pace Analytical Services Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pace Analytical Services Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Intertek Group (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Intertek Group (United Kingdom) Revenue: by Geography 2023
  • Figure 29. DYNALABS (United States) Revenue, Net Income and Gross profit
  • Figure 30. DYNALABS (United States) Revenue: by Geography 2023
  • Figure 31. RD Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 32. RD Laboratories (United States) Revenue: by Geography 2023
  • Figure 33. ADPEN Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 34. ADPEN Laboratories (United States) Revenue: by Geography 2023
  • Figure 35. West Pharmaceutical Services, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. West Pharmaceutical Services, Inc. (United States) Revenue: by Geography 2023
  • Figure 37. Boston Analytical (United States) Revenue, Net Income and Gross profit
  • Figure 38. Boston Analytical (United States) Revenue: by Geography 2023
  • Figure 39. Accuratus Labs (United States) Revenue, Net Income and Gross profit
  • Figure 40. Accuratus Labs (United States) Revenue: by Geography 2023
  • Figure 41. Microbac (United States) Revenue, Net Income and Gross profit
  • Figure 42. Microbac (United States) Revenue: by Geography 2023
  • Figure 43. Charles River Laboratories International, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Charles River Laboratories International, Inc. (United States) Revenue: by Geography 2023
  • Figure 45. ARLBioPharma, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 46. ARLBioPharma, Inc. (United States) Revenue: by Geography 2023
  • Figure 47. Global Pharmaceutical Testing Services: by Testing Service USD Million (2025-2030)
  • Figure 48. Global Pharmaceutical Testing Services: by End-User USD Million (2025-2030)
  • Figure 49. South America Pharmaceutical Testing Services Share (%), by Country
  • Figure 50. Asia Pacific Pharmaceutical Testing Services Share (%), by Country
  • Figure 51. Europe Pharmaceutical Testing Services Share (%), by Country
  • Figure 52. MEA Pharmaceutical Testing Services Share (%), by Country
  • Figure 53. North America Pharmaceutical Testing Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Eurofins Scientific SE (Luxembourg)
  • SGS (France)
  • Envigo (United States)
  • Exova Group PLC (United Kingdom)
  • PPD Inc. (United States)
  • Pace Analytical Services Inc. (United States)
  • Intertek Group (United Kingdom)
  • DYNALABS (United States)
  • RD Laboratories (United States)
  • ADPEN Laboratories (United States)
  • West Pharmaceutical Services, Inc. (United States)
  • Boston Analytical (United States)
  • Accuratus Labs (United States)
  • Microbac (United States)
  • Charles River Laboratories International, Inc. (United States)
  • ARLBioPharma, Inc. (United States)
Additional players considered in the study are as follows:
Lapuck Laboratories, Inc. (United States) , BioScreen Inc. (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 223 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmaceutical Testing Services Quantitative research analysis
Global Pharmaceutical Testing Services Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.

Know More About Global Pharmaceutical Testing Services Report?

Have a Query? Click Here

Other Related Reports

Laboratory Informatics Comprehensive Study by Type (Laboratory Information Management Systems, Electronic Lab Notebooks, Scientific Data Management Systems, Laboratory Execution Systems, Chromatograp...
$ 3750
Teleradiology Services Comprehensive Study by Application (Radiology Information System (RIS), Picture Archiving and Communication System (PACS), Integrated (RIS and PACS), Others), Services (General...
$ 3750
Helicobacter Pylori Testing Comprehensive Study by Type (With Endoscopy, Without Endoscopy), Application (Physical Examination Center, Hospitals, Clinics, Others), Tests (Blood Antibody Test, Urea Br...
$ 3450
Transcatheter Mitral Valve Repair and Replacement Comprehensive Study by Type (Transcatheter Mitral Valve Repair, Transcatheter Mitral Valve Replacement), Application (Hospitals, Clinics, Others), Pr...
$ 3650
mHealth Solutions Comprehensive Study by Type (Wellness Service, Monitoring Service, Diagnostic Service, Treatment, Information and reference), Application (General Healthcare and Fitness, Medication...
$ 3750
Facial Implants Comprehensive Study by Type (Silicone facial implants, EPTFE implants and sheeting), Application (Hospitals, Super specialty clinics, Ambulatory Surgical Centers), Product (Chin impla...
$ 3450